Excited to announce that we are finishing recruitment for CAPITAL DOREMI-2: the first blinded RCT of inotrope vs placebo in cardiogenic shock.

New post on NephroPOCUS.com "#VExUS Beyond Volume: What Tricuspid Regurgitation Teaches Us" #POCUS #Nephpearls #FOAMed 🔗nephropocus.com/2026/09/23/v…

1) Sotatercept is amazing effective for PAH but effects on the RV have been inconsistent. @CircAHA we show that RV contractility truly decreases after sotatercept with no change in RV PA coupling -> the surrogates we’ve chased for years with vasodilators ahajournals.org/eprint/ZXDH2…

Lean la excelente reseña que se realizó en KidneyNews acerca del la nueva fórmula para convertir los valores de una gasometria venosa a arterial. Realizada por el Dr Batlle @Dan_Batlle y su equipo play.google.com/store/apps/d… Con esto evitaríamos muchas punciones arteriales innecesarias

If your LVOT VTI is normal to elevated, limited role in giving fluids to improve shock - instead, consider chronotropy or map augmentation if still hypoperfused

💊 "Aspirin Withdrawal in Patients With Coronary Artery Disease" (2026 JACC STATE-OF-THE-ART REVIEW) jacc.org/doi/10.1016/j.jacc.…

Precipitants of Acute Heart Failure: A State-of-the-art Review from an International Expert Group CCR Journal Watch criticalcarereviews.com/late…

Mitral Valve *ProlapSAM* @denisamuraru @alex1708ander @NMerke @eromerodorta @StellEkaterina @alexsfelixecho @echo_batman @echo_stepbystep @VerwerftJan @echotalk @drahmedmohsen85 @argulian @iamritu

📍A must read!!! Clinical Management of Myocardial Infarction @CircAHA ahajournals.org/doi/10.1161/…

Hypoperfusion-Shock Continuum in Acute Decompensated Heart Failure CCR Journal Watch criticalcarereviews.com/late…

Hypertensive crisis in the critically ill CCR Journal Watch criticalcarereviews.com/late…

Step up your RV assessment skills for patients with a PE. 🎩 tip to the authors. eddyjoemd.com/foamed

📌Lipid lowering therapy in venous thromboembolism. A Clinical Consensus Statement of the @escardio #PositionPaper #LLT

Published today, Infective Endocarditis: Diagnosis, Antibiotic Therapy and Management: A Scientific Statement from the American Heart Association. professional.heart.org/en/sc… Infective endocarditis (IE) remains a life-threatening infection with substantial short- and long-term risks for those who survive an initial episode. Interest in IE has grown substantially due to notable shifts in its epidemiology and rising incidence. 📷 Multidisciplinary approach to infective endocarditis care.

GLP-1 EN ENFERMEDADES CARDIOVASCULARES Revisión imperdible de @ESC_Journals 👌 🔴Cambio de paradigma: DBT⏩Enf CV 🔴Mecanismo de acción 🔴Beneficio en DBT 🔴Beneficio en obesidad sin DBT 🔴Beneficio en HFpEF+obesidad 🔴Efectos adversos 🔴Nuevos fármacos academic.oup.com/eurjpc/adva…

Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry publications.ersnet.org/cont… @SPLF_SocPneumo @pulmotension @OrphaLung

Pulmonary Arterial Hypertension: a Practice Guideline for the Treatment publications.ersnet.org on September 7, 2026. ERS Congress, Barcelona-Spain. @EuroRespSoc @ERSpublications 🫁💗❤️‍🩹🩻🩺💊💉

Defining Clinically Meaningful Within-Patient Changes in Heart Failure: @JACCJournals : #HeartFailure Position Statement This #JACCHF position statement proposes a pragmatic framework for defining clinically meaningful within-patient change across commonly used #HF outcomes #JACCHF @ACCinTouch jacc.org/doi/10.1016/j.jchf.… @JACCJournals

Contemporary #decongestion strategies in acute heart failure: an individual patient data analysis of three randomized controlled trials #AHF @ESC_Journals @EJHFEiC @jozinetm @WilfriedMullens academic.oup.com/eurjhf/adva…

𝐉𝐮𝐬𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝! Original Article by J. Sundh et al.: Metoprolol in Chronic Obstructive Pulmonary Disease without Cardiovascular Disease eviden.cc/4ctWTvo #ERSCongress | @EuroRespSoc @SundhJosefin @FrobertOle